108
Participants
Start Date
May 1, 2022
Primary Completion Date
June 30, 2022
Study Completion Date
June 30, 2022
Huashi Baidu granule
Patients were given HSBDG the day after randomization, with a dose of 2.5g for age 3 to 6 years, 5 g for age 7 to 12 years, and 10 g for age 13 to 18 years, twice daily for 5 consecutive days.
compound pholcodine oral solution
Patients were given compound pholcodine oral solution (Bright Future Pharmaceuticals Factory, Hong Kong, CHN) the day after randomization, with a dose of 5 ml for age 3 to 6 years and 10 ml for age 7 to 18 years, three times daily for 5 consecutive days.
Shanghai children's medical center, Shanghai
Shanghai Children's Medical Center
OTHER